In 2016, our clinical trial portfolio has seen a two-fold increase. A wide network of study sites and well-refined project management methodologies allow OCT to retain its stably leading position of the most reliable and experienced CRO in Eastern Europ
More than 200 clinical trials completed. Successfully passed over 40 audits by leading pharmaceutical companies. OCT has 80 long-standing strategic partners. The team now counts 200 people.
After reaching the point in its development where it could operate independently, OCT’s data management department spun-off into a separate company — Data MATRIX — with a team of 40 specialists.
Completion of development of the IWRS — a tool for randomization of subjects and management of blinded drug supplies completed. The total number of employees operating across 6 offices reaches 90 people.